Latest / tv.qiagenbioinformatics.com
QIAGEN and NVIDIA collaboration to advance AI driven drug discovery
NVIDIA and QIAGEN are collaborating to bring trustworthy, contextual AI to drug discovery. By integrating NVIDIA's accelerated computing and the BioNeMo platform with QIAGEN Digital Insights' manually curated biomedical knowledge graphs, cited in over 70,000 peer-reviewed publications; the collaboration aims to transform how disease mechanisms, therapeutic targets, and biomarkers are identified. Using a graph-based AI approach built on G-Retriever, the solution delivers 5–10x better performance than standard RAG pipelines, giving researchers answers they can trust, defend, and act on. In this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.